Venerated And Vital: Using Lipid Based Delivery For Fast And Efficient Early Phase Development
Summary: Introduced to the pharmaceutical industry decades ago, lipid-based drug delivery systems are the most well-studied and widely utilized technology among all available bioavailability enhancement technologies.
- Lipid-based drug delivery systems have delivered more than 60 unique drug molecules to market – and counting.
- With today’s increasingly complex new molecules emerging from R&D, optimizing bioavailability for early phase molecules is critical to their success.
Not only do lipid-based drug delivery systems provide a reliable solution for poorly soluble molecules, they also allow for efficient and scalable dose formulation solutions which can accelerate progress to clinic and beyond, especially for orphan and breakthrough therapies.